Abstract
Since the relatively recent regulatory approval for clinical use in both Europe and North America, 7-Tesla (T) MRI has been adopted for clinical practice at our institution. Based on this experience, this article reviews the unique features of 7-T MRI neuroimaging and addresses the challenges of establishing a 7-T MRI clinical practice. The underlying fundamental physics principals of high-field strength MRI are briefly reviewed. Scanner installation, safety considerations, and artifact mitigation techniques are discussed. Seven-tesla MRI case examples of neurologic diseases including epilepsy, vascular abnormalities, and tumor imaging are presented to illustrate specific applications of 7-T MRI. The advantages of 7-T MRI in conjunction with advanced neuroimaging techniques such as functional MRI are presented. Seven-tesla MRI produces more detailed information and, in some cases, results in specific diagnoses where previous 3-T studies were insufficient. Still, persistent technical issues for 7-T scanning present ongoing challenges for radiologists.
Similar content being viewed by others
Data availability of data and material (data transparency)
Not applicable.
References
United States Food and Drug Administration (2017) FDA clears first 7 T magnetic resonance imaging device. https://www.fda.gov/news-events/press-announcements/fda-clears-first-7t-magnetic-resonance-imaging-device. Accessed 15 Jan 2020
Barisano G, Sepehrband F, Ma S, Jann K, Cabeen R, Wang DJ, Toga AW, Law M (2019) Clinical 7 T MRI: are we there yet? A review about magnetic resonance imaging at ultra-high field. Br J Radiol 92(1094):20180492. https://doi.org/10.1259/bjr.20180492
Feldman RE, Delman BN, Pawha PS, Dyvorne H, Rutland JW, Yoo J, Fields MC, Marcuse LV, Balchandani P (2019) 7 T MRI in epilepsy patients with previously normal clinical MRI exams compared against healthy controls. PLoS One 14(3):e0213642. https://doi.org/10.1371/journal.pone.0213642
Ladd ME, Bachert P, Meyerspeer M, Moser E, Nagel AM, Norris DG, Schmitter S, Speck O, Straub S, Zaiss M (2018) Pros and cons of ultra-high-field MRI/MRS for human application. Prog Nucl Magn Reson Spectrosc 109:1–50. https://doi.org/10.1016/j.pnmrs.2018.06.001
Balchandani P, Naidich TP (2015) Ultra-high-field MR neuroimaging. American Journal of Neuroradiology 36(7):1204–1215. https://doi.org/10.3174/ajnr.A4180
Deistung A, Rauscher A, Sedlacik J, Stadler J, Witoszynskyj S, Reichenbach JR (2008) Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn Reson Med 60(5):1155–1168. https://doi.org/10.1002/mrm.21754
Dury RJ, Falah Y, Gowland PA, Evangelou N, Bright MG, Francis ST (2019) Ultra-high-field arterial spin labelling MRI for non-contrast assessment of cortical lesion perfusion in multiple sclerosis. European Radiology 29(4):2027–2033. https://doi.org/10.1007/s00330-018-5707-5
Hoff MN, McKinney A, Shellock FG, Rassner U, Gilk T, Watson RE Jr, Greenberg TD, Froelich J, Kanal E (2019) Safety considerations of 7-T MRI in clinical practice. Radiology 292(3):509–518. https://doi.org/10.1148/radiol.2019182742
Theysohn JM, Kraff O, Eilers K, Andrade D, Gerwig M, Timmann D, Schmitt F, Ladd ME, Ladd SC, Bitz AK (2014) Vestibular effects of a 7 Tesla MRI examination compared to 1.5 T and 0 T in healthy volunteers. PLoS One 9(3):e92104. https://doi.org/10.1371/journal.pone.0092104
Poser BA, Setsompop K (2018) Pulse sequences and parallel imaging for high spatiotemporal resolution MRI at ultra-high field. NeuroImage 168:101–118. https://doi.org/10.1016/j.neuroimage.2017.04.006
Teeuwisse WM, Brink WM, Webb AG (2012) Quantitative assessment of the effects of high-permittivity pads in 7 Tesla MRI of the brain. Magn Reson Med 67(5):1285–1293. https://doi.org/10.1002/mrm.23108
Fagan AJ, Welker KM, Amrami KK, Frick MA, Watson RE, Kollasch P, Chebrolu V, Felmlee JP (2019) Image artifact management for clinical magnetic resonance imaging on a 7 T scanner using single-channel radiofrequency transmit mode. Investigative radiology 54(12):781–791. https://doi.org/10.1097/rli.0000000000000598
van Gemert J, Brink W, Webb A, Remis R (2019) High-permittivity pad design tool for 7 T neuroimaging and 3 T body imaging. Magn Reson Med 81(5):3370–3378. https://doi.org/10.1002/mrm.27629
van der Zwaag W, Francis S, Head K, Peters A, Gowland P, Morris P, Bowtell R (2009) fMRI at 1.5, 3 and 7 T: characterising BOLD signal changes. NeuroImage 47(4):1425–1434. https://doi.org/10.1016/j.neuroimage.2009.05.015
Gizewski ER, de Greiff A, Maderwald S, Timmann D, Forsting M, Ladd ME (2007) fMRI at 7 T: whole-brain coverage and signal advantages even infratentorially? NeuroImage 37(3):761–768. https://doi.org/10.1016/j.neuroimage.2007.06.005
Nguyen DK, Mbacfou MT, Nguyen DB, Lassonde M (2013) Prevalence of nonlesional focal epilepsy in an adult epilepsy clinic. Can J Neurol Sci 40(2):198–202. https://doi.org/10.1017/s0317167100013731
Winston GP, Micallef C, Kendell BE, Bartlett PA, Williams EJ, Burdett JL, Duncan JS (2013) The value of repeat neuroimaging for epilepsy at a tertiary referral centre: 16 years of experience. Epilepsy Research 105(3):349–355. https://doi.org/10.1016/j.eplepsyres.2013.02.022
Veersema TJ, van Eijsden P, Gosselaar PH, Hendrikse J, Zwanenburg JJM, Spliet WGM, Aronica E, Braun KPJ, Ferrier CH (2016) 7 tesla T2*-weighted MRI as a tool to improve detection of focal cortical dysplasia. Epileptic Disorders 18(3):315–323. https://doi.org/10.1684/epd.2016.0838
De Ciantis A, Barba C, Tassi L, Cosottini M, Tosetti M, Costagli M, Bramerio M, Bartolini E, Biagi L, Cossu M, Pelliccia V, Symms MR, Guerrini R (2016) 7 T MRI in focal epilepsy with unrevealing conventional field strength imaging. Epilepsia 57(3):445–454. https://doi.org/10.1111/epi.13313
Maranzano J, Dadar M, Rudko DA, De Nigris D, Elliott C, Gati JS, Morrow SA, Menon RS, Collins DL, Arnold DL, Narayanan S (2019) Comparison of multiple sclerosis cortical lesion types detected by multicontrast 3 T and 7 T MRI. American Journal of Neuroradiology. 40:1162–1169. https://doi.org/10.3174/ajnr.A6099
Mainero C, Benner T, Radding A, van der Kouwe A, Jensen R, Rosen BR, Kinkel RP (2009) In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 73(12):941–948. https://doi.org/10.1212/WNL.0b013e3181b64bf7
Kilsdonk ID, Jonkman LE, Klaver R, van Veluw SJ, Zwanenburg JJ, Kuijer JP, Pouwels PJ, Twisk JW, Wattjes MP, Luijten PR, Barkhof F, Geurts JJ (2016) Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study. Brain 139(Pt 5):1472–1481. https://doi.org/10.1093/brain/aww037
Dixon JE, Simpson A, Mistry N, Evangelou N, Morris PG (2013) Optimisation of T2*-weighted MRI for the detection of small veins in multiple sclerosis at 3 T and 7 T. Eur J Radiol 82(5):719–727. https://doi.org/10.1016/j.ejrad.2011.09.023
Absinta M, Sati P, Schindler M, Leibovitch EC, Ohayon J, Wu T, Meani A, Filippi M, Jacobson S, Cortese IC, Reich DS (2016) Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. J Clin Invest 126(7):2597–2609. https://doi.org/10.1172/jci86198
de Rotte AA, Groenewegen A, Rutgers DR, Witkamp T, Zelissen PM, Meijer FJ, van Lindert EJ, Hermus A, Luijten PR, Hendrikse J (2016) High resolution pituitary gland MRI at 7.0 tesla: a clinical evaluation in Cushing’s disease. Eur Radiol 26(1):271–277. https://doi.org/10.1007/s00330-015-3809-x
Law M, Wang R, Liu C-SJ, Shiroishi MS, Carmichael JD, Mack WJ, Weiss M, Wang DJJ, Toga AW, Zada G (2019) Value of pituitary gland MRI at 7 T in Cushing’s disease and relationship to inferior petrosal sinus sampling: case report. Journal of Neurosurgery JNS 130(2):347–351. https://doi.org/10.3171/2017.9.Jns171969
Patel V, Liu C-SJ, Shiroishi MS, Hurth K, Carmichael JD, Zada G, Toga AW (2020) Ultra-high field magnetic resonance imaging for localization of corticotropin-secreting pituitary adenomas. Neuroradiology 62(8):1051–1054. https://doi.org/10.1007/s00234-020-02431-x
United States Food and Drug Administration (2014) Criteria for significant risk investigations of magnetic resonance diagnostic devices. guidance for industry and food and drug administration staff. Food and Drug Administration Center for Devices and Radiological Health, Rockville https://www.fda.gov/regulatory-information/search-fda-guidance-documents/criteria-significant-risk-investigations-magnetic-resonance-diagnostic-devices-guidance-industry-and. Accessed 4/24/2020 2020
International Electrotechnical Commission (2015) IEC 60601-2-33:2010: Medical electrical equipment - Part 2-33: Particular requirements for the basic safety and essential performance of magnetic resonance equipment for medical diagnosis, 3rd ed. with amendments. International Electrotechnical Commission. https://www.iecee.org/ords/f?p=106:49:0::::FSP_STD_ID:2647. Accessed 15 Jan 2020
Cao Z, Yan X, Gore JC, Grissom WA (2020) Designing parallel transmit head coil arrays based on radiofrequency pulse performance. Magn Reson Med 83(6):2331–2342. https://doi.org/10.1002/mrm.28068
Shellock FG (2020) MRISAFETY.com. Shellock R & D Services, Inc. http://www.mrisafety.com/index.html. Accessed 24 Apr 2020
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest/competing interests (include appropriate disclosures)
The authors declare that they have no conflict of interest.
Ethics approval (include appropriate approvals or waivers)
For this type of study (review article), formal consent is not required.
Consent to participate (include appropriate statements)
Not applicable.
Consent for publication (include appropriate statements)
Not applicable.
Code availability (software application or custom code)
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key points
• Seven-tesla MRI is a valuable addition to neuroradiology clinical practice which can improve diagnostic capability for certain neurologic diseases where conventional field strength scanning may fail.
• Successful clinical implementation of 7-T MRI requires special consideration of unit siting, patient safety factors, and artifact mitigation techniques.
• Functional MRI at 7-T provides higher signal to noise ratio and blood oxygenation level-dependent contrast, allowing for more specific functional localization in some cases.
• To fully realize the potential of 7-T MRI, unmet needs remain regarding receive coils, safe ancillary equipment and anesthesia capabilities, and expanded use with advanced neuroimaging techniques.
Rights and permissions
About this article
Cite this article
Burkett, B.J., Fagan, A.J., Felmlee, J.P. et al. Clinical 7-T MRI for neuroradiology: strengths, weaknesses, and ongoing challenges. Neuroradiology 63, 167–177 (2021). https://doi.org/10.1007/s00234-020-02629-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-020-02629-z